All
Calquence Combo May Improve Outcomes in Chronic Lymphocytic Leukemia
Calquence plus Venclexta with or without Gazyva significantly improved progression-free survival in patients with untreated CLL.
Presurgical Opdivo Plus Yervoy Has Potential Clinical Benefit in NSCLC
Among patients with resectable non-small cell lung cancer, Opdivo plus Yervoy has displayed potential long-term clinical benefits versus chemotherapy.
How the FDA Approval of Imfinzi Advances Small Cell Lung Cancer Treatment
The FDA has approved Imfinzi for some adults with limited-stage small cell lung cancer.
FDA Approval of Ensacove Adds to the Toolkit for ALK-Positive NSCLC
An expert explained the importance of the FDA’s approval of Ensacove for patients with ALK-positive non-small cell lung cancer.
What the FDA Approval of Bizengri Means for Patients With NRG1-Positive NSCLC
The FDA granted its first approval for a systemic therapy for patients with non-small cell lung cancer with an Neuregulin 1 gene fusion.
What’s On the Horizon for Small Cell Lung Cancer Research?
On the heels of two FDA approvals in lung cancer treatments, what innovations are next?
Looking For The Light After MDS
As a cancer survivor, I talk about where to look for the light when in utter darkness.
A Patient’s Journey With Colon Cancer and Her Advocacy Mission
Melissa Ursini, diagnosed with stage 2 colon cancer, shares her journey to raise awareness and encourage early detection through colonoscopies.
What Patients Need to Know About Appealing Insurance Denials
The CEO of Triage Cancer discussed the “best-kept secret” of the health care system in an interview with CURE.
Artificial Intelligence Enhances Polyp Detection in Colorectal Cancer
Artificial intelligence aids in polyp detection, enhancing colonoscopy effectiveness and reducing the risk of colorectal cancer progression in patients.
Thermal Ablation Noninferior to Surgery in Small-Size Colorectal Liver Metastases
Treatment with thermal ablation was noninferior to surgical resection in small-size colorectal liver metastases, according to the COLLISION trial.
Organ-Sparing Treatments Bring New Life After Cancer
Avoiding surgery for rectal cancer, Sarah Rack of Memphis traveled to Houston for treatment every three weeks for 18 months.
Becoming a Better Version of Me After Breast Cancer
A revelation has given me perspective for the New Year, inspiring me to embrace change, set new goals and upgrade myself to a better version in 2025.
Colostomies and Colon Cancer, a Lifesaving Choice, Not a Last Resort
Dr. Andreas M. Kaiser explains how a colostomy may preserve a patient’s health and help to avoid colorectal cancer complications.
Brukinsa Combo Shows Efficacy and Safety For Double-Expressor Lymphoma
Brukinsa plus R-CHOP demonstrated high efficacy and durable responses in double-expressor lymphoma, with manageable safety, supporting further phase 3 trials.
Biomarkers, Genetic Testing and More Make Way in GU Cancers
Dr. Park shares the three biggest takeaways, in his opinion, to have come out of the ASCO GU Symposium, highlighting studies across kidney, bladder and prostate cancers.
Verzenio Combo May Improve Survival in HR+/HER2– Advanced Breast Cancer
Verzenio plus Faslodex improved progression-free survival in HR+/HER2– advanced breast cancer after CDK/6i failure, with a manageable safety profile.
Better Understanding Genetic Mutations Influence in Cancer Care
Dr. Guru Sonpavde emphasized the importance of better understanding how genetic mutations influence the treatment of cancer care, particularly GU cancers.
Breast Cancer And Depending On The Kindness Of Strangers
I reflect on my unexpected bond with a neighbor during my breast cancer treatment, finding comfort in his company when I needed someone to talk to.
Enhertu Associated With Survival Increase in HER2+ Metastatic Gastric Cancer
Enhertu improved overall survival versus chemotherapy in HER2-positive metastatic gastric cancer, prompting an interim analysis and potential regulatory approvals.
Checkpoint Inhibitor Therapy and ISRT Maintains Outcomes in Younger Patients With cHL
Replacing transplant and chemo with CI-based therapy and ISRT maintains survival, reduces side effects in younger patients with classic Hodgkin lymphoma.
FDA Approves Tevimbra Plus Chemotherapy For Some With Esophageal Cancer
The FDA approved Tevimbra with chemotherapy for adults with unresectable or metastatic esophageal squamous cell carcinoma whose tumors express PD-L1.
Expert Explains Safety of Krazati Regimen For Treating Colorectal Cancer
Krazati plus Erbitux is well tolerated in KRAS G12C-mutant metastatic colorectal cancer, with manageable side effects and less immune suppression.
Immune Checkpoint Inhibitors For Cancer Associated With Psoriasis Risk
Researchers have discovered a strong association between the use of immune checkpoint inhibitors for cancer treatment and a risk of new onset psoriasis.
Accepting My Colon Cancer Diagnosis at A Young Age
Being diagnosed with colon cancer at 34 was difficult, but choosing happiness and acceptance helped me find peace through mindfulness, nature and family.
Rusfertide Elicits Promising Responses in Polycythemia Vera
Among phlebotomy-dependent patients with polycythemia vera, the addition of rusfertide to standard-of-care treatment resulted in positive responses.
FDA Accepts Ordspono Resubmission in R/R Follicular Lymphoma Treatment
The FDA has accepted the resubmission of the BLA of Ordspono for review in relapsed/refractory follicular lymphoma following previous systemic therapy.
My Journey With Squamous Cell Carcinoma
A patient shares his experience with a squamous cell carcinoma diagnosis, treatment and recovery.
First Patient With Small Cell Lung Cancer Dosed With Peluntamig
The first patient with small cell lung cancer has been dosed in a trial of peluntamig (PT217) combined with chemotherapy.
First Patient Dosed With HLD-0915 for mCRPC in First-In-Human Trial
The first patient has been dosed in a first-in-human clinical trial evaluating HLD-0915 for metastatic castration-resistant prostate cancer.
